P. Bradford

Molecular Medicine · 2001–2021

A researcher in the Science corpus: 4 papers; trusts 7 researchers and is trusted by 12 researchers here, as inferred from the citation graph.

Subfields

• Molecular Medicine — 46 citations into it; #39 of 296 by trust here, #145 by citations
• Endocrinology — 25 citations into it
• Molecular Biology — 17 citations into it; #4,705 of 17,773 by trust here, #10,506 by citations
• Pharmacology — 14 citations into it; #884 of 1,112 by trust here, #945 by citations
• Applied Microbiology and Biotechnology — 9 citations into it; #4 of 31 by trust here, #11 by citations
• Epidemiology — 7 citations into it
• Pollution — 7 citations into it

Whom P. Bradford trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. K. Bush
2. L. Poirel
3. G. Jacoby
4. P. Nordmann
5. R. Bonnet
6. D. Livermore
7. J. Pitout

Who trusts P. Bradford overall

1. K. Bush
2. J. Pitout
3. 古谷 良輔
4. David L. Paterson
5. R. Cantón
6. S. Navon-Venezia
7. C. Giske
8. A. Davidson
9. G. Jacoby
10. R. Bonnet

Papers from P. Bradford's perspective

Ordered by how strongly the researchers P. Bradford trusts endorse each paper. Same corpus, a different order for every researcher.

1. Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes (Antimicrobial Agents and Chemotherapy)
2. OXA-48-like carbapenemases: the phantom menace. (Journal of Antimicrobial Chemotherapy)
3. CTX-M Enzymes: Origin and Diffusion (Front. Microbio.)
4. Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in France (Antimicrobial Agents and Chemotherapy)
5. Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India (Antimicrobial Agents and Chemotherapy)
6. Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae (Antimicrobial Agents and Chemotherapy)
7. Updated Functional Classification of β-Lactamases (Antimicrobial Agents and Chemotherapy)
8. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study (Lancet. Infectious Diseases (Print))
9. AmpC β-lactamases: what do we need to know for the future?
10. Escherichia coli ST131, an Intriguing Clonal Group (Clinical Microbiology Reviews)

Their papers

• Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat (2001) — 2,973 citations
• Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection (2021) — 688 citations
• Epidemiology of β-Lactamase-Producing Pathogens (2020) — 678 citations
• β-Lactams and β-Lactamase Inhibitors: An Overview. (2016) — 1,123 citations